[3 years of polychemotherapy of pleuro-pulmonary cancer. Apropos of 95 cases].
D000728:Androgens / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000627:therapeutic use; D001389:Azirines / Q000627:therapeutic use; D001984:Bronchial Neoplasms / Q000188:drug therapy*; D002277:Carcinoma / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004357:Drug Synergism; D005472:Fluorouracil / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D037102:Lectins / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000188:drug therapy*; D008466:Mechlorethamine / Q000627:therapeutic use; D015122:Mercaptopurine / Q000627:therapeutic use; D008654:Mesothelioma / Q000188:drug therapy; D008727:Methotrexate / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D010997:Pleural Neoplasms / Q000188:drug therapy*; D013852:Thiotepa / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use
D000728:Androgens; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D001389:Azirines; D005938:Glucocorticoids; D006834:Hydrazines; D037102:Lectins; D008466:Mechlorethamine; D014747:Vinblastine; D003520:Cyclophosphamide; D013852:Thiotepa; D015122:Mercaptopurine; D010653:Phenylbutazone; D001205:Ascorbic Acid; D005472:Fluorouracil; D008727:Methotrexate
Trois ans de polychimiothérapie des cancers pleuro-pulmonaires. A propos de 95 observations.